Vizpime T 1000mg/125mg Injection
Marketer
Vistica Life Sciences
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Vizpime T 1000mg/125mg Injection
Ceftibuten and Sulbactam injection, 1000mg/125mg, combats bacterial infections by hindering microbial proliferation. This dual-antibiotic formulation requires administration by a healthcare provider. Complete the prescribed dosage, even with symptom improvement. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site inflammation. Severe reactions or persistent symptoms necessitate immediate medical attention. Allergic responses (rash, itching, swelling, respiratory distress) demand prompt medical care. Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While typically not impairing driving ability, refrain from driving if experiencing somnolence or dizziness.
Primary Ingredients of Vizpime T 1000mg/125mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Vizpime T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Vizpime T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Vizpime T 1000mg/125mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Vizpime T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Vizpime T 1000mg/125mg Injection works:
Vizpime T Injection (1000mg Cefepime/125mg Tazobactum) combines the antibiotic Cefepime with the beta-lactamase inhibitor Tazobactum. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial survival. Tazobactum counteracts bacterial enzymes that would otherwise neutralize Cefepime, thus broadening Cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Vizpime T 1000mg/125mg Injection concurrently with alcohol. Seek medical advice.
PregnancySAFE IF PRESCRIBED
The injectable medication, Vizpime T 1000mg/125mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, research involving human subjects is currently insufficient.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can safely use Vizpime T 1000mg/125mg Injection. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Following administration of Vizpime T 1000mg/125mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
The administration of Vizpime T 1000mg/125mg Injection requires careful consideration in individuals with impaired kidney function. Dosage modification of Vizpime T 1000mg/125mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Vizpime T 1000mg/125mg Injection in patients with liver disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary for this patient group, however, professional medical advice is recommended.
What if you forget to take Vizpime T 1000mg/125mg Injection :
Omit a dose of Vizpime T 1000mg/125mg Injection? Seek your physician's advice.
Facts to Know About Vizpime T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently